COSTEM 2019 | How do we bridge to transplant in relapsed ALL?

Name: How do we bridge to transplant in relapsed ALL?
Uploaded: 2019-10-25T00:00:00.000Z
Duration: 2 min 19 s
Description: Peihua Lu, MD, Lu Daopei hospital, Beijing, China, provides insight as to how we might bridge the gap to transplant in relapsed acute lymphoblastic leukemia (ALL) with CAR-T cell therapy. This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

Peihua Lu • 25 Oct 2019

COSTEM 2019

Acute Lymphoblastic Leukemia Leukemia CAR-T

Peihua Lu, MD, Lu Daopei hospital, Beijing, China, provides insight as to how we might bridge the gap to transplant in relapsed acute lymphoblastic leukemia (ALL) with CAR-T cell therapy. This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.